Prime Minister Fumio Kishida, second from left, and transport minister Tetsuo Saito are seen while an airline employee receives a third dose of a COVID-19 vaccine at Haneda Airport on Saturday.
15:29 JST, February 12, 2022
ANA Holdings Inc. and Japan Airlines Co. began the third round of COVID-19 vaccinations for their employees on Saturday, ahead of other major companies.
Pilots and flight attendants who work on international flights are eligible to be vaccinated at this time.
A total of 10 employees from both airline companies gathered in a conference room at Haneda Airport Terminal 1, which was the designated vaccination site, at around 10 a.m. on the day.
“I hope many people will feel reassured while traveling on a plane,” said a JAL flight attendant after being vaccinated.
Prime Minister Fumio Kishida visited the site on the day. Kishida wants 1 million booster shots to be administered per day by the second half of this month. On Tuesday, the government announced its plan to move up the rollout for workplace vaccinations to Feb. 21 and urged companies to begin administering boosters earlier if they can.
An ANA employee receives a third dose of a COVID-19 vaccine at Haneda Airport on Saturday.
The government plans to distribute to workplaces 7.6 million doses by the end of February and 2 million more doses by the end of March.
Top Articles in Society
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
15 Measles Patients Confirmed in Tokyo in Past 6 Days; 1 May Have Come into Contact with Many in Shibuya
-
Bus Carrying 40 Passengers Catches Fire on Chuo Expressway; All Evacuate Safely
-
Ibaraki Pref.’s 1st Foreign Bus Driver Hired in Tsukuba
JN ACCESS RANKING
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Japan PM Takaichi’s Cabinet Resigns en Masse
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
Japan Figure Skating Legend Yuzuru Hanyu Is Proud Disaster Survivor and Gold Medalist, Vows to Continue Support Efforts
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed

